Active Ingredient: ETHINYL ESTRADIOL; NORGESTIMATE
Proprietary Name: TRI-ESTARYLLA
Dosage Form; Route of Administration: TABLET; ORAL-28
Strength: 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090793
Product Number: 001
Approval Date: Jan 30, 2013
Applicant Holder Full Name: XIROMED PHARMA ESPANA SL
Marketing Status:
Prescription
Patent and Exclusivity Information
